Clinical Trial Update: A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

This entry describes a Phase I dose-escalation trial of the investigational agent BMS-641988 in men with castration-resistant prostate cancer, which has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BMS-641988

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED